The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis
View ORCID ProfileVageesh Jain, Paula Lorgelly
doi: https://doi.org/10.1101/2021.08.30.21262821
Vageesh Jain
1Institute for Global Health, University College London, London, WC1E 6JB, UK
MBBSPaula Lorgelly
2Institute of Epidemiology and Health Care, University College London, London WC1E 7HB, UK
PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplementary File[supplements/262821_file05.docx]
Posted August 31, 2021.
The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis
Vageesh Jain, Paula Lorgelly
medRxiv 2021.08.30.21262821; doi: https://doi.org/10.1101/2021.08.30.21262821
Subject Area
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (652)
- Anesthesia (174)
- Cardiovascular Medicine (2522)
- Dermatology (211)
- Emergency Medicine (386)
- Epidemiology (12002)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3915)
- Geriatric Medicine (367)
- Health Economics (655)
- Health Informatics (2531)
- Health Policy (975)
- Hematology (352)
- HIV/AIDS (814)
- Medical Education (390)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3677)
- Nursing (205)
- Nutrition (548)
- Oncology (1911)
- Ophthalmology (557)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1077)
- Primary Care Research (436)
- Public and Global Health (6354)
- Radiology and Imaging (1342)
- Respiratory Medicine (847)
- Rheumatology (389)
- Sports Medicine (335)
- Surgery (426)
- Toxicology (51)
- Transplantation (180)
- Urology (156)